Cardiolipin Antibody IgM (aCL IgM) Biomarker Testing
It measures IgM antibodies to cardiolipin linked to antiphospholipid syndrome risk, with convenient ordering and clear results through Vitals Vault/Quest.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
Cardiolipin Antibody IgM (often shown as anticardiolipin IgM or aCL IgM) is a blood test that looks for an immune signal that can be associated with abnormal blood clotting and certain pregnancy complications.
A single result rarely tells the whole story. This marker is most useful when it is interpreted alongside your symptoms, your history (such as a prior clot or pregnancy loss), and related antiphospholipid antibody tests.
If you are trying to understand whether you should test, or you already have a positive result and want to know what “low,” “in range,” or “high” means, the goal is to translate the lab report into next steps you can review with your clinician.
Do I need a Cardiolipin Antibody IgM test?
You may consider a Cardiolipin Antibody IgM test if you or your clinician are evaluating possible antiphospholipid syndrome (APS), an autoimmune condition where certain antibodies are linked to an increased tendency to form blood clots. Testing is commonly prompted by an unexplained deep vein thrombosis (DVT), pulmonary embolism, stroke or transient ischemic attack at a younger age, or recurrent clots without a clear trigger.
This test is also often discussed in fertility and pregnancy care when there is a history of recurrent pregnancy loss, stillbirth, severe preeclampsia, placental insufficiency, or unexplained growth restriction. In those settings, the result is not a standalone explanation, but it can be one piece of a broader workup.
You might also see it ordered if you have another autoimmune diagnosis (such as lupus) and your care team is assessing clot risk, or if you have lab findings like low platelets that raise suspicion for an antiphospholipid antibody pattern.
Because false positives and temporary elevations can happen, this test is best used to support clinician-directed care rather than self-diagnosis. If your result is abnormal, the usual next step is confirming persistence and checking the full APS-related antibody profile.
This is a laboratory immunoassay performed in a CLIA-certified lab; results support clinical decision-making but do not diagnose antiphospholipid syndrome on their own.
Lab testing
Order Cardiolipin Antibody IgM through Vitals Vault
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
With Vitals Vault, you can order Cardiolipin Antibody IgM testing without a referral and complete your blood draw through the Quest network. That can be helpful if you are gathering data before a clinician visit, confirming a past result, or rechecking a borderline value on the timeline your care team recommends.
After your results post, PocketMD can help you summarize what the marker means, what follow-up tests are typically paired with it (such as lupus anticoagulant and beta-2 glycoprotein I antibodies), and what questions to bring to your clinician based on your history.
If you are tracking a prior positive, Vitals Vault makes it easier to repeat the same test and compare trends over time, which matters because APS classification depends on persistent positivity rather than a one-time spike.
- Order online and draw at Quest locations
- Clear result display with context for follow-up testing
- PocketMD support to prepare for your clinician visit
Key benefits of Cardiolipin Antibody IgM testing
- Helps evaluate whether antiphospholipid antibodies could be contributing to unexplained blood clots.
- Adds useful context in pregnancy loss or placenta-related complications when APS is part of the differential.
- Distinguishes IgM anticardiolipin patterns from IgG, which can have different clinical weight depending on the situation.
- Supports APS workups when combined with lupus anticoagulant and beta-2 glycoprotein I antibody testing.
- Guides whether repeat testing at least 12 weeks later is needed to confirm persistence.
- Helps your clinician interpret clot risk in the setting of lupus or other autoimmune disease.
- Creates a baseline you can trend over time when monitoring a prior positive or borderline result.
What is Cardiolipin Antibody IgM?
Cardiolipin is a phospholipid (a type of fat molecule) found in cell membranes, especially in mitochondria. Cardiolipin antibodies are autoantibodies, meaning your immune system is reacting to a molecule that is normally part of your body.
The IgM part describes the antibody class. IgM antibodies can appear earlier in immune responses and can sometimes be transient, which is one reason a single positive result does not automatically mean you have a chronic condition.
When cardiolipin antibodies are persistently present at clinically significant levels, they can be part of the antiphospholipid antibody (aPL) family associated with antiphospholipid syndrome (APS). APS is defined by a combination of clinical events (like thrombosis or specific pregnancy complications) and laboratory criteria (persistent aPL positivity).
How this relates to antiphospholipid syndrome (APS)
APS is not diagnosed from symptoms alone or from labs alone. Clinicians look for a pattern: a relevant clinical event plus persistent positivity on one or more aPL tests. Anticardiolipin IgM is one of the classic aPL tests, but it is interpreted alongside anticardiolipin IgG, beta-2 glycoprotein I antibodies (IgG/IgM), and lupus anticoagulant testing.
Why “IgM” can be tricky
Isolated IgM positivity (with negative IgG and negative lupus anticoagulant) can be less specific, and mild elevations may be temporary. That does not mean it is irrelevant, especially if you have a strong clinical history, but it does mean confirmation and context are important.
What do my Cardiolipin Antibody IgM results mean?
Low (negative) Cardiolipin Antibody IgM
A low or negative result means this specific antibody was not detected or was below the lab’s cutoff. If you are being evaluated for APS, a negative IgM does not rule it out, because other antibodies (anticardiolipin IgG, beta-2 glycoprotein I antibodies, or lupus anticoagulant) may still be present. Your clinician will usually interpret a negative result based on your history of clots or pregnancy complications and whether other aPL tests were checked at the same time.
In-range (within the reference interval)
An in-range result is generally treated the same as negative: it does not suggest a cardiolipin IgM antibody pattern. If you have symptoms or a history that still raises concern, the next step is often to ensure the full antiphospholipid antibody panel was done and that testing was timed appropriately. In some cases, repeat testing is considered if the initial workup occurred during an acute illness or soon after a clot, when results can be harder to interpret.
High (positive) Cardiolipin Antibody IgM
A high result means your immune system is producing IgM antibodies that bind cardiolipin. The clinical significance depends on how elevated it is, whether it is persistent on repeat testing at least 12 weeks later, and whether you also have other positive aPL tests. A single positive can be temporary, so clinicians often confirm persistence before labeling it an APS-type finding. If you have had a clot, pregnancy complications, or autoimmune disease, a positive result may influence how your clinician assesses risk and plans follow-up.
Factors that influence Cardiolipin Antibody IgM
Acute infections and inflammatory states can sometimes cause temporary anticardiolipin antibody elevations, particularly in IgM. Timing also matters: testing during or soon after a clot, surgery, or hospitalization may complicate interpretation, especially if other coagulation tests are being run. Different labs and methods can use different units and cutoffs, so it helps to compare results from the same lab when trending. Medications that affect clotting (like anticoagulants) do not usually change anticardiolipin antibody levels directly, but they can affect related tests such as lupus anticoagulant, which is why clinicians coordinate the full workup carefully.
What’s included
- Cardiolipin Ab (Igm)
Frequently Asked Questions
What is a Cardiolipin Antibody IgM test used for?
It is used to look for IgM anticardiolipin antibodies, which can be part of an antiphospholipid antibody pattern. Clinicians use it when evaluating unexplained blood clots, certain pregnancy complications, or suspected antiphospholipid syndrome (APS), usually alongside other related tests.
Do I need to fast for Cardiolipin Antibody IgM?
Fasting is not typically required because this is an antibody test. If you are having other labs drawn at the same time (like lipids or glucose), follow the fasting instructions for those tests.
What does a positive anticardiolipin IgM mean?
A positive result means the antibody was detected above the lab’s cutoff. It may be clinically meaningful if it is clearly elevated and remains positive when repeated at least 12 weeks later, especially if you also have a history of thrombosis or specific pregnancy complications and/or other positive antiphospholipid antibody tests.
Can infections cause a false positive cardiolipin IgM?
Yes. Some infections and short-term inflammatory states can lead to temporary anticardiolipin antibody positivity, particularly IgM. That is one reason clinicians often repeat testing after 12 weeks to confirm persistence before making long-term conclusions.
How is cardiolipin IgM different from lupus anticoagulant?
Cardiolipin IgM is an antibody measured by an immunoassay, while lupus anticoagulant is assessed using clot-based coagulation tests (screening and confirmatory steps). They are different parts of the antiphospholipid antibody evaluation, and either can be positive while the other is negative.
Should I retest if my result is borderline or weakly positive?
Often, yes. APS-related laboratory criteria rely on persistent positivity, so clinicians commonly repeat anticardiolipin testing at least 12 weeks later, ideally when you are not acutely ill. Your clinician may also recommend checking the full aPL profile at the same time to see whether there is a consistent pattern.
Can this test explain miscarriage or infertility by itself?
Not by itself. A positive cardiolipin IgM can be a clue in an APS workup, but pregnancy loss and infertility have many possible causes. Clinicians interpret this result alongside your pregnancy history, ultrasound and placental findings when available, and other labs, and they may confirm persistence before attributing risk to antiphospholipid antibodies.